- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/42 - Cancer antigens
Patent holdings for IPC class A61K 40/42
Total number of patents in this class: 639
10-year publication summary
|
1
|
0
|
1
|
3
|
16
|
34
|
50
|
19
|
23
|
378
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4323 |
17 |
| The Regents of the University of California | 19929 |
14 |
| Immatics Biotechnologies GmbH | 1157 |
11 |
| Juno Therapeutics, Inc. | 410 |
11 |
| Fred Hutchinson Cancer Center | 450 |
11 |
| Board of Regents, The University of Texas System | 5803 |
10 |
| Kite Pharma, Inc. | 414 |
10 |
| Memorial Sloan-Kettering Cancer Center | 1930 |
10 |
| Novartis AG | 10850 |
8 |
| The Board of Trustees of the Leland Stanford Junior University | 6416 |
8 |
| The General Hospital Corporation | 4731 |
8 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2833 |
8 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 949 |
7 |
| Sloan-Kettering Institute for Cancer Research | 520 |
7 |
| Iovance Biotherapeutics, Inc. | 343 |
7 |
| Memorial Hospital for Cancer and Allied Diseases | 294 |
7 |
| Regeneron Pharmaceuticals, Inc. | 4253 |
6 |
| Immunitybio, Inc. | 372 |
6 |
| City of Hope | 991 |
5 |
| CRISPR Therapeutics AG | 364 |
5 |
| Other owners | 463 |